On Soin et Nature, discover Mylan Viatris, a major player in the French healthcare sector, offering more than 1,500 products covering numerous therapeutic areas. With a strong local industrial presence and a broad range of generic medications, Mylan Viatris is committed to making treatments accessible and reliable to support patients in their daily lives.
More detailsAt Mylan Viatris, universal access to healthcare is a top priority. More than just a goal, it is a comprehensive vision that guides every aspect of the company’s operations. Today, Mylan Viatris is a key player in the pharmaceutical sector, serving more than1 billion patients worldwide—including 68 million in France—thanks to its unparalleled infrastructure and expertise. This mission is based on a fundamental principle: to provide high-quality healthcare solutions that are accessible to all and tailored to patients’ diverse needs.
With 450 active pharmaceutical ingredients and more than 1,500 products, Mylan Viatris is now the leading pharmaceutical company by volume in the French market—a result that illustrates the impact and scope of its efforts. With more than 400 million packages sold annually, every second in France, 12 patients benefit from a Mylan Viatris product. These figures reflect a clear commitment: to support patients throughout their care journey, from diagnosis to treatment, including prevention.
One of Mylan Viatris’s key strengths is its industrial presence in France. With two production and packaging facilities located in the Lyon region, the brand supports French expertise and actively contributes to the local economy. These modern and innovative facilities enable the manufacture of medications that meet the strictest standards for quality and safety.
Beyond its infrastructure, it is Mylan Viatris’s 1,350 employees who embody the brand’s commitment every day. These professionals, experts in their respective fields, put their expertise to work for patients, ensuring tailored and effective healthcare solutions—whether for chronic conditions, acute treatments, or everyday ailments.
At Mylan Viatris, access to care goes beyond simply providing medications. The company also works toward sustainable development by integrating environmentally responsible practices into its operations. For example, at its manufacturing sites, significant efforts are made to reduce the environmental footprint: 75% to 89% of the waste generated is recycled or repurposed. This responsible approach is part of a broader vision in which public health and protecting the planet go hand in hand.
In addition, the brand leads prevention and awareness initiatives, such as combating hospital-acquired infections and improvingtreatment adherence through appropriate packaging. These programs, designed for both healthcare professionals and patients, reinforce Mylan Viatris’s positive impact on the healthcare system.
Finally, Mylan Viatris collaborates with numerous organizations to support vital causes. For more than 15 years, it has partnered withthe Association Petits Princes, which helps seriously ill children fulfill their dreams, and it actively participates in the efforts of the Tulipe association, dedicated to sending pharmaceutical products to crisis zones.
Innovation is at the heart of Mylan Viatris’s strategy. The company does not merely produce high-quality generic drugs; it also seeks to develop integrated solutions to improve the patient care journey. This includes tools for prevention, screening, and treatment adherence, thereby enabling comprehensive management of medical conditions.
The Global Healthcare Gateway® is one of Mylan Viatris’s flagship initiatives. This global network connects patients, healthcare professionals, and business partners to cutting-edge medical solutions, thereby strengthening access to care on an international scale.
With an impressive array of products, Mylan Viatris has established itself as a key leader in the pharmaceutical industry. Its portfolio covers nearly 100% of therapeutic areas, offering tailored solutions for a wide range of conditions. Here are the main categories and their objectives:
Thanks to this comprehensive coverage, Mylan Viatris has established itself as a trusted solution for patients and healthcare professionals.
By choosing Mylan Viatris, you’re choosing much more than just a medication. You’re embracing a healthcare solution that combines quality, accessibility, and sustainability. Each product is designed to rigorous standards, using carefully selected raw materials and undergoing regular testing to ensure optimal efficacy.
Mylan Viatris does more than just produce medications; it is also committed to improving prevention and patient support. Through its diverse product lines, awareness initiatives, and partnerships with organizations, the brand demonstrates that it puts people at the heart of its priorities.
The generic drugs produced by Mylan Viatris contribute to significant savings for national healthcare systems every year. These savings help fund medical innovation while maintaining universal access to treatments.
With initiatives ranging from local production to global programs, Mylan Viatris is working toward a healthier future. So why wait? Trust a brand that combines innovation, expertise, and a commitment to people.
